Myriad Genetics announced the addition of the new Universal Plus Panel to its proprietary Foresight carrier screen, screening up to 272 genes linked to serious inherited conditions.
The panel encompasses 39 conditions highlighted in the American College of Medical Genetics and Genomics (ACMG) practice resource for carrier screening. It employs next-generation sequencing (NGS) and other technologies to spot pathogenic variants underlying genetically inheritable diseases. It also offers a detailed report of test results and provides access to genetic counseling resources.
The company states that guideline recommendations, associated condition severity, condition prevalence, clinical actionability of results, and detection sensitivity are considered when selecting genes for the test panel.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.